Clinuvel Pharmaceuticals
CUV.AX
#7382
Rank
HK$2.49 B
Marketcap
HK$49.84
Share price
-3.74%
Change (1 day)
-39.59%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: HK$0.26 Billion

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are HK$59.01 Million. In 2024 the company made an earning of HK$0.26 Billion, an increase over its 2023 earnings that were of HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024HK$0.26 B12.42%
2023HK$0.23 B27.77%
2022HK$0.18 B22.23%
2021HK$0.15 B114.01%
2020HK$70.18 M-29.03%
2019HK$98.89 M32.76%
2018HK$74.49 M75.24%
2017HK$42.5 M-332.09%
2016-HK$18.32 Million-70.52%
2015-HK$62.13 Million53.56%
2014-HK$40.46 Million-16.31%
2013-HK$48.35 Million-37.85%
2012-HK$77.78 Million-18%
2011-HK$94.85 Million25.86%
2010-HK$75.37 Million-21.79%
2009-HK$96.36 Million-11.73%
2008-HK$0.11 Billion80.71%
2007-HK$60.41 Million-2.86%
2006-HK$62.2 Million-4.95%
2005-HK$65.44 Million60.55%
2004-HK$40.76 Million97.37%
2003-HK$20.65 Million50.62%
2002-HK$13.71 Million121.22%
2001-HK$6.2 Million254.48%
2000-HK$1.75 Million